The Company is specialized in the development, manufacturing and commercialization of medical as well as cosmetic and beauty device products. The core business is the INJEX30 needle free injection system for subcutaneous and intradermal deliveries of injectables. Numerous therapeutic solutions may be based on needle free drug delivery thus making the INJEX30 system the innovation tool for the development of Transdermal Therapies.
The Company is the first manufacturer of needle free injection systems with European CE, the US FDA, and SFDA approval for the Chinese market. The strongest applications of the INJEX Medical Lineare the use of local anesthesia, especially in dentistry, and the administration of insulin for diabetics. Vaccination and hormone treatment are also applications where the Company assumes a high growth potential.
In June 2016, the Company has added a new product line in the field of cosmetics & beauty. The INJEX Beauty Lineincludes an innovative method of injections using hyaluronic acid to smooth wrinkles, vitamin B to refresh the skin and vitamin C to treat dark spots.
The Company is currently launching the business on a global scale. The Company needs to position itself in the key markets with the sales networks in Asia, Australia, North America, Russia and the Middle East, while INJEX is establishing a direct sales channel in Germany.
The virtually painless needle free injection is a premium device product that is also gentle on the skin, and the risks of infections as well as injuries are very low. Therefore the Company has also been approached by NGOs helping the medical industry in developing countries since it is expected that using the needle free injection may avoid the spread of Aids, i. e. caused by the use of improperly sterilized needles.
It is Managements Vision to establish INJEX Pharma GmbH as a drug delivery specialist and become The Drug Delivery Company